TLXTelix Pharmaceuticals Limited Stock Analysis

Exchange: NASDAQ | Sector: Healthcare | Industry: Biotechnology

Current Price: $9.11 (-0.22% today)

Market Cap: $3.09B

P/E (TTM): -404.00

Forward P/E (FY1): 181.80

EPS Growth: 219.2%

Relative Strength (RS%): 31

-54.4% from 52-week high

Back to Scanner

TLX

NASDAQRS 31Score 27

Telix Pharmaceuticals Limited

HealthcareBiotechnology$3.09B2 setups passing
$9.11
-0.2% ($0.02)
-54.4% from 52W High
P/E (TTM)
-404.00
Fwd P/E
181.80
PEG
0.70
Analyst Upside
EPS Growth
219.2%
Gross Margin
50.8%
ROE
-2.1%
D/E
1.26
Div Yield
0.0%
Avg Volume
170.3K

Price Chart

Key Levels

SMA 200
$10.16
SMA 50
$7.70
Price
$9.11
52W High
$19.98

Setup Radar

2/8 passing
📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst